Published February 18, 2010 | Version v1

Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Description

n/a

Files

fulltext.pdf

Files (167.6 kB)

Name Size
md5:5c535ea2084c85ffae5242632e4d4bf8
167.6 kB Preview Download